Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: NDoC Pacer 8-29-13 HTC TPL royalty rate/s determination/discus...
This one came off the HTC file..
Corrected EXHIBIT D to Weinstein Declaration filed by HTC
http://photos.imageevent.com/banos/t3/Corrected%20EXHIBIT%20D%20to%20Weinstein%20Declaration%20filed%20by%20HTC.pdf
including the following excerpts and exhibits:
115. For HTC the amount of the lump sum payment the parties would agree to based on the above royalty rate and royalty base [actual rate/base is redacted] is $10 million. A small portion of that amount, or $30,000, would relate to sales post-trial.
larger view: http://photos.imageevent.com/banos/t3/Royalty%20rates.jpg
larger view: http://photos.imageevent.com/banos/t3/Royalty%20rates%20tiers.jpg
New Message
Please
login
to post a reply